Pharmaceutical giant Johnson & Johnson lost a major legal battle Monday, when an Oklahoma judge ordered the corporation to pay more than $572 million for downplaying the risks of opioid addiction as it promoted its related products to doctors.
In his ruling Cleveland County District Judge Thad Balkman argued that Johnson & Johnson had through its “misleading marketing and promotion of opioids created a nuisance” in the state, according to NBC News.
“The opioid crisis has ravaged the state of Oklahoma. It must be abated immediately,” Balkman continued. “For this reason, I’m entering an abatement plan that consists of costs totaling $572,102,028 to immediately remediate the nuisance.”
He added, “The defendants’ opioid marketing, in its multitude of forms, was false, deceptive and misleading.”
Michael Ullmann, Johnson & Johnson’s executive vice president and general counsel, said in a statement after the ruling that the corporation accepts no responsibility for creating the opioid epidemic in Oklahoma and intends to appeal Balkman’s decision.
“This judgment is a misapplication of public nuisance law that has already been rejected by judges in other states,” Ullmann said in a statement. “The unprecedented award for the state’s ‘abatement plan’ has sweeping ramifications for many industries and bears no relation to the Company’s medicines or conduct.”
In its own statement, Johnson & Johnson also recognized the seriousness of the opioid crisis, while at the same time depicting itself as a positive actor in addressing the problem.
“The opioid crisis is a complex public health issue that demands a public health response,” it said. “The company continues to collaborate to help patients, families and communities in need.”
“Building on our legacy in public health, we are working with frontline health care professionals, academic institutions, policymakers, online communities and others to address the unmet needs of those impacted by this crisis. To date, the company has sponsored independently developed education programs for tens of thousands of doctors, nurses and pharmacists across America, helping to better equip them to fight substance abuse and addiction,” it continued. “The company is also collaborating with academic institutions to identify evidence-based best practices that can empower nurses and other health care practitioners to effectively respond to the opioid crisis at the community level. Based on more than 130 years of experience, these collaborations are where the company can have the greatest impact.”
This is not the first time that Johnson & Johnson has found itself on the wrong side of a lawsuit. Last year, the company was forced to pay $4.69 billion to 22 women who developed ovarian cancer after using the company’s talcum powder products. The amount included $4.14 billion in punitive damages and $550 million in compensatory damages.
Mark Lanier, an attorney for the women, said in a statement at the time that “for over 40 years, Johnson & Johnson has covered up the evidence of asbestos in their products. We hope this verdict will get the attention of the J&J board and that it will lead them to better inform the medical community and the public about the connection between asbestos, talc, and ovarian cancer. The company should pull talc from the market before causing further anguish, harm, and death from a terrible disease. J&J sells the same powders in a marvelously safe corn starch variety. If J&J insists on continuing to sell talc, they should mark it with a serious warning.”
We’re not backing down in the face of Trump’s threats.
As Donald Trump is inaugurated a second time, independent media organizations are faced with urgent mandates: Tell the truth more loudly than ever before. Do that work even as our standard modes of distribution (such as social media platforms) are being manipulated and curtailed by forces of fascist repression and ruthless capitalism. Do that work even as journalism and journalists face targeted attacks, including from the government itself. And do that work in community, never forgetting that we’re not shouting into a faceless void – we’re reaching out to real people amid a life-threatening political climate.
Our task is formidable, and it requires us to ground ourselves in our principles, remind ourselves of our utility, dig in and commit.
As a dizzying number of corporate news organizations – either through need or greed – rush to implement new ways to further monetize their content, and others acquiesce to Trump’s wishes, now is a time for movement media-makers to double down on community-first models.
At Truthout, we are reaffirming our commitments on this front: We won’t run ads or have a paywall because we believe that everyone should have access to information, and that access should exist without barriers and free of distractions from craven corporate interests. We recognize the implications for democracy when information-seekers click a link only to find the article trapped behind a paywall or buried on a page with dozens of invasive ads. The laws of capitalism dictate an unending increase in monetization, and much of the media simply follows those laws. Truthout and many of our peers are dedicating ourselves to following other paths – a commitment which feels vital in a moment when corporations are evermore overtly embedded in government.
Over 80 percent of Truthout‘s funding comes from small individual donations from our community of readers, and the remaining 20 percent comes from a handful of social justice-oriented foundations. Over a third of our total budget is supported by recurring monthly donors, many of whom give because they want to help us keep Truthout barrier-free for everyone.
You can help by giving today. Whether you can make a small monthly donation or a larger gift, Truthout only works with your support.